Sunday 24 March 2013
Cancer biomarkers can be used for developing assays for clinical diagnosis, identifying patient-s response to a particular drug, optimizing personalized drug treatment regimen (drug dose, drug treatment schedule etc.), monitoring the efficacy of treatment (disease stage, tumor progression, tumor recurrence etc.) and in cancer theranostics.
With the growing trend towards the advancement of personalized medicine concept, companion diagnostic tools may play a significant role in patient stratification by identifying patients with positive clinical response to an existing or novel treatment method.